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Background: This study examined the psychometric properties of the Cardiac Depression Scale (CDS) in a sample
of coronary heart disease (CHD) patients.
Methods: A total of 152 patients were diagnosed with coronary heart disease and were administered the CDS
along with the Beck Depression Inventory- 2 (BDI-2) and the State Trait Anxiety Inventory (STAI) 3.5-months after
cardiac hospitalization.
Results: The CDS’s factorial composition in the current sample was similar to that observed in the original scale.
Varimax-rotated principal-components analyses extracted six factors, corresponding to mood, anhedonia, cognition,
fear, sleep and suicide. Reliability analyses yielded internal consistency α - coefficients for the six subscales ranging
from 0.62 to 0.82. The CDS showed strong concurrent validity with the BDI-II (r = 0.64). More patients were classified
as severely depressed using the CDS. Both the CDS and the BDI-2 displayed significantly strong correlations with
the STAI (r = 0.61 and r = 0.64), respectively.
Conclusions: These findings encourage the use of the CDS for measuring the range of depressive symptoms in
those with CHD 3.5 months after cardiac hospitalization.
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A high incidence of depression has been reported in those
with coronary heart disease (CHD) specifically in those
who have had coronary artery bypass graft surgery [1-3],
those who have experienced myocardial infarction [2,4]
and following angina [5,6]. One in every four people with
CHD have been reported to meet diagnostic criteria for
major depression [7-11]. Mild depression is also com-
monly found in those hospitalised with CHD and has been
estimated to affect from one in four [9,11] to one in three
of these individuals [12]. Depression has been found to
affect the prognosis of patients with CHD even though
some of these patients may not always meet the DSM-IV
criteria for major depression [13]. Those with CHD who
are more likely to experience mild to moderate depres-
sion, (based on a BDI score of 10 or more), have been* Correspondence: litzak@unimelb.edu.au
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distribution, and reproduction in any mediumfound to have a subsequent mortality compared with
patients with BDI scores less than 10 when assessed at 6
and 18 months following the event [14-16]. Similar find-
ings have also been found in patients with angina, (who
scored greater than 10 on the BDI), who were more likely
to die of a cardiac event or to experience a nonfatal car-
diac event within 1 year of the initial hospital admission
compared to patients with a BDI score of less than 10 [6].
Both mild to moderate and severe depression at
hospitalization have also been found to be strong predic-
tors of depression 3 months after cardiac hospitalization
[17]. Longitudinal studies have found that individuals with
CHD who are depressed are less likely to adhere to their
treatment regime and lifestyle recommendations following
a cardiac event [18] and might be at higher risk of subse-
quent cardiac events [19]. Co-morbid depression and low
social support has also been found to seriously impact
prognosis with a 3 to 5 fold increase risk of death found in
those with CHD who had poor social support [20].
A range of depression assessment tools have been used
to measure depressive symptoms in CHD patients. Thesetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Characteristics of depressed and non-depressed
groups
Measures Total Nondepressed Depressed P
(N = 152) (N = 93) (N = 59)
Medical History
Angina 45 (29.6%) 24 (25.8%) 21 (35.6%) .198
Stent 42 (27.6%) 25 (26.9%) 17 (28.8%) .795
Myocardial Infarction 32 (21.1%) 19 (20.4%) 13 (22%) .813
CABG 20 (13.2%) 15 (16.1%) 5 (8.5%) .174
Arrhythmia 13 (8.6%) 10 (10.8%) 3 (5.1%) .223
Gender .779
Male 101 (66.4%) 61 (60.4%) 40 (39.6%)
Female 51 (33.6%) 32 (62.7%) 19 (37.3%)
Born overseas 90 (59.2%) 46(49.5%) 44 (74.6%) .001
Current smoker 19 (12.5%) 11 (57.9%) 8 (42.1%) .719
Currently working 19 (12.9%) 14 (73.7%) 5 (26.3%) .257
Married 115 (75.7%) 70 (60.9%) 45 (39.1%) .888
Other health
problem
113 (74.3%) 64 (70.3%) 49 (89.1%) .009
Taking heart
medication
121 (79.6%) 70 (78.7%) 51 (92.7%) .025
Note. CABG = Coronary artery bypass grafting.
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the Hospital Anxiety and Depression Scale (HADS) [22],
the Center for Epidemiologic Studies Depression Scale
(CES-D) [23] and the Cardiac Depression Scale (CDS)
[24]. One criticism of the use of non disease specific
tools in CHD patients is that symptoms such as fatigue
may be mistaken for cardiac-related symptoms which may
result in under-detection of the somatic symptoms of de-
pression which have been attributed instead to cardiac
problems [25].
The CDS has been developed as a depression scale to ac-
curately assess depression in cardiac patients [24]. The ori-
ginal CDS has been shown to comprise of seven reliable
and distinct components which include Mood, Anhedonia,
Cognition, Fear, Sleep, Suicide and Hopelessness. However
recent studies have found a six factor solution for the CDS
[26,27].
The CDS has been employed to assess for a range of
depressive symptoms in cardiac patients with various
diagnoses and at different time points including use with
ambulatory cardiac outpatients with a range of diagnoses
including angina, heart failure, post-myocardial infarc-
tion, valvular heart cardiac disease and arrhythmias [24];
those with an acute coronary syndrome (due to myocar-
dial ischaemia or infarction) who were assessed at 2-weeks
post-hospital discharge [13]; and a cardiac rehabilitation
population which consisted of a mixed group of cardiac
patients including those who had a myocardial infarction,
heart failure, coronary artery bypass graft surgery, angio-
plasty or a stent procedure who were assessed while
undergoing cardiac rehabilitation [27].
However, further validation of the CDS in a CHD popu-
lation who are medically stable and have settled into their
community surroundings after cardiac hospitalization is
needed given that studies have shown that around one
third of those with CHD meet criteria for depression 3–
4 months after a cardiac event [28]. The current paper
presents the examination of the psychometric properties
of the CDS as a measure of depressive symptoms in those
who had CHD and were 3.5-months post cardiac hospital-
isation, by investigating its factorial composition (as an
index of its construct validity), its reliability and also com-
paring the CDS with the BDI-2 in its ability to discrimin-
ate those with mild, moderate and severe depression.
Methods
Participants and procedure
One hundred and fifty two outpatients with CHD who
had been admitted for a cardiac procedure were recruited
from two Coronary Care Units in Melbourne, Victoria.
Recruitment took part between June, 2009 and September,
2011. Initial recruitment took place while the patient was
still in hospital or straight after discharge. Of the 356
patients admitted to the coronary care units of twohospitals which were approached, 105 patients were not
contactable and 99 did not want to participate, resulting
in a final sample of 152 patients (response rate: 59%). The
152 patients who participated in this study consisted of
101 males (66.4%) and 51 females (33.6%) and ranged in
age from 45 to 92 years (M = 70.34 years, SD = 8.18).
Table 1 reports the characteristics of the depressed and
non-depressed groups. As can be seen in Table 1, all parti-
cipants had a diagnosis of CHD with 45 (29.6%) reporting
angina, 42 (27.6%) treated with a coronary stent proced-
ure, 32 (21.1%) who had a myocardial infarction,
20 (13.2%) who had coronary artery bypass graft surgery,
and 13 (8.6%) who had angina. The majority of the sample
was male, married, overseas born, not actively working or
currently smoking at that time, and reported at least one
other chronic health problem.
Ethics approval for this study was granted by Monash
University, Southern Health and Western Health Ethics
Committees. Inclusion criteria included having a diagno-
sis of CHD and no known psychiatric problems. During
their hospital stay or within a week after their hospital
discharge researchers contacted participants to describe
the study and ask whether potential participants would
like an explanatory statement and a consent form sent
out to them. Potential participants were also asked
whether it would be feasible for the researcher to re-
contact them at a 3 month post discharge period to
undertake a 1-hour face to face interview with them at a
location of their choice. Those that agreed were sent out
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form with a reply paid envelope to complete and return
to the researcher prior to the interview or it was
collected on the day of the interview. At the 3 month
post-discharge time point, the researchers re-contacted
participants by phone to organise an interview time. All
questionnaires were administered by way of interview
for all participants. Patients were interviewed 3-months
after cardiac hospitalisation to minimise any possible in-
fluence of the hospital stay on levels of depression. Inter-
views took place at either the researcher’s office at
Monash University or in the participant’s home.Measures
Depression
The 26-item Cardiac Depression Scale (CDS) [24] is
designed to assess depression in adult cardiac popula-
tions. The CDS was developed as an alternative to more
general depression scales that were considered to be too
insensitive and unresponsive to depressive symptoms
experienced by cardiac patients [24]. Average CDS
scores have been reported in different cardiac groups
with higher scores observed in those with heart failure
compared with those with acute myocardial infarction
[13]. All statements on the CDS are scored on a 7-point
Likert-type scale ranging from ‘strongly disagree’ (1) to
‘strongly agree’ (7). Participants are asked to rate how
strongly they agree or disagree with each statement. A
scale point of 4 indicates neither disagreement nor
agreement with the item. Seven items are reverse-scored.
Higher scores on the CDS indicate more severe depres-
sion. The CDS has fewer items that refer to somatic
symptoms of depression compared to the BDI-2. The
total CDS score is the sum of all items and ranges from
26 to 182. Cut-off scores to indicate mild, moderate or
severe depression were not provided by the original
authors for the CDS. However, a cut-off score of 90 for
mild depression and 100 or above has been recom-
mended to detect individuals with more severe depres-
sion [27, Wise et al.]. The 21-item Beck Depression
Inventory- Version 2 (BDI-2) [21] is a widely used meas-
ure of psychological and physical symptoms of depres-
sion in adults. Each item consists of four statements
indicating the degree of severity of the symptom. The
items assess cognitive, behavioural, affective and somatic
symptoms. Responses to items covered ‘the past two
weeks, including today’. Scores range from 0 to 3 with
0 indicating absence of the symptoms and higher values
indicating greater severity of the symptom. The BDI-2
score can be grouped into mild (10–19), moderate (20–25)
and severe (>25) symptoms [21]. The internal reliability
for the CDS and the BDI-2 in the current study indicated
an α –coefficient of 0.91 for both scales.Anxiety
The State-Trait Anxiety Inventory (state version) (STAI)
[29] is a 20-item indictor of anxiety in adults. The scale
evaluates feelings of tension, nervousness, worry and ap-
prehension ‘in the past two weeks, including today’.
Responses are on a 4-point Likert scale ranging from (0)
‘not at all’ and (3) ‘very much so’ with higher scores
reflecting higher severity. In the current sample, the
STAI showed excellent reliability (α = 0.93).
Quality of Life
The 26-item World Health Organisation Quality of Life
scale (Brief version) (WHOQOL-BREF) [30] was used to
measure Quality of Life. The WHOQOL-BREF asks about
an individual’s quality of life in four domains including
physical health, psychological health, social relationships
and environment. Higher scores denote higher quality of
life. The WHOQOL-BREF also contains one question
about an individual’s perception of overall quality of life
and a question about their perception of their overall
health. The internal reliability for the four domains of the
scale indicated alpha coefficients ranging from 0.81 to 0.85.
Social Support
The 12-item Perceived Social Support Scale (PSSS) [31]
assesses perceived social support from family, friends and
others. Higher scores indicated higher perceived social
support. The internal consistency for this scale in this
sample indicated an alpha coefficient of 0.92. The 7-item
Enriched Social Support Instrument (ESSI) [32] measures
functional social support particularly emotional support in
cardiac patients. Higher scores indicate higher levels of so-
cial support. The ESSI has been previously used to exam-
ine level of social support and to assess changes in
patients’ social support after cardiac treatment. The alpha
coefficient for the ESSI in the current sample was 0.86.
Results
Factor Analysis
In order to reproduce the factor structure reported pre-
viously we undertook the factor analysis procedures used
by Hare and Davis (1996) [24] and Wise, Harris and
Carter (2006) [27]. Using the principal component ex-
traction method with an eigenvalue > 1, the first-order
factor analysis extracted six factors instead of the seven
reported in the original study by Hare and Davis (1996)
[24]. These six factors accounted for 63.14% of the vari-
ance. Further varimax rotation testing was performed
and the individual items in relation to the six-factor so-
lution were reproduced using a loading criterion of 0.40
as a cut-off point. Table 2 reports the factors extracted
from the CDS by principal components analysis with
varimax rotation and the Cronbach alpha’s for each fac-
tor. As can be seen, factor loadings ranged from 0.41 to
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Mood, Anhedonia, Cognition, Fear, Sleep and Suicide
subscales were observed to load onto factors 1, 2, 3, 4, 5
and 6 respectively. Items on the fear factor found in pre-
vious studies loaded on the Mood and Suicide factors.
Similarly, items on the Anhedonia factor found in previ-
ous studies loaded on the Mood and Cognition factors.Reliability analysis
The total 26-item CDS scale showed good reliability (α =
0.91). As seen in Table 2, the Cronbach alpha coefficients
for the six CDS subscales were acceptable and ranged from
0.62 (Factor 6: Suicide) to 0.82 (Factor 2: Anhedonia).Table 2 Factors extracted from the CDS by principal compone
Item number Items
13 The possibility of sudden death worries me (fear)
18 Things which i regret most about my life are bothering
me (mood)
21 I become tearful more easily than before (mood)
22 I seem to get more easily irritated by others than befo
(anhedonia)
24 I lose my temper more easily nowadays (mood)
25 I feel frustrated (mood)
4R I get pleasure from life at present (anhedonia)
23R I feel independent and control in my life (anhedonia)
1 I have dropped many of my interests and activities
(anhedonia)
3 I can’t be bothered doing anything much (anhedonia)
8 I am not the person i used to be (anhedonia)
16 I get hardly anything done (anhedonia)
15R My mind is as fast and alert as always (cognition)
19R I gain as much pleasure from leisure activities as i used
(anhedonia)
20R My memory is as good as it always was (cognition)
2R My concentration is as good as it ever was (cognition)
5 I am concerned about the uncertainty of my health (fe
17 My problems are not yet over (fear)
6 I may not recover properly (fear)
7 My sleep is restless and disturbed (sleep)
9 I wake up in the early hours of the morning and canno
back to sleep (sleep)
12R I feel in good spirits (suicide)
26 I am concerned about my capacity for sexual activity (
10 I feel like im living on borrowed time (fear)
11 Dying is the best solution for me (suicide)
14 There is only misery in the future for me (suicide)
Cronbach’s alphaConcurrent validity
Pearson’s correlation coefficients were used to established
the CDS’s concurrent validity with a moderate to high cor-
relation between the relevant scales deemed as acceptable
(r > = 0.3). A significant moderate to high correlation be-
tween the CDS and the BDI-2 scale (r = 0.65, p < 0.001)
and between the BDI-2 and the STAI (r = 0.64, p < 0.001)
was observed. Similarly, moderate to high correlations
were found between the CDS and the STAI scale (r = 0.61,
p < 0.001), the CDS and the physical QOL subdomain
(r = −0.64, p < 0.001), psychological QOL subdomain
(r = −0.60, p < 0.001), social QOL subdomain (r = −0.46,
p < 0.001) and environmental QOL subdomain (r = −0.43,
p < 0.001), and the PSSS (r = −0.42, p < 0.001). A weakernts analysis with varimax rotation (N = 152)
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(r = 0.18, p < 0.05).Relationships between the CDS and the BDI-2
Analyses of variance were used to determine the differ-
ences between the depressed and the non-depressed
groups on the depression, anxiety, quality of life and so-
cial support measures. Based on previous research, in-
clusion in the depressed group in the current study was
determined by a BDI-2 score of > = 10 [13]. Results of
the analyses of variance can be seen in Table 3. Partici-
pants in the depressed group were more likely to score
significantly higher on the CDS, BDI-2, STAI and lower
on the QOL physical, psychological, social and environ-
ment subdomains, and on the ESSI and PSSS compared
to the non-depressed group. The recommended cut-offs
for the CDS and the BDI-2 employed in previous studies
were used in the current study to examine how many
outpatients were classified in the mild, moderate and se-
vere depression groups [13,26,27]. Specifically, BDI-2
cut-off score of 10 for mild-moderate depression and 19
for severe depression and CDS cut-off score of 90 for
mild to moderate depression and 100 for severe depres-
sion were used. The percentages of patients with mild to
moderate and severe depression according to the CDS
and the BDI-2 are presented in Table 4. As can seen, the
CDS classified 72 (47.4%) of the participants as not
depressed compared to 93 (61.2%) of the participants by
the BDI-2 scale. Similar results for the two scales were
found when classifying the mild to moderately depressed
participants in the sample. Specifically, the CDS classi-
fied 38 (25%) of the participants as mild to moderately
depressed compared to the BDI-2 which classified 37
(24.3%) of the participants. However, it seemed that the
CDS classified more participants as severely depressed
in the current sample compared to the BDI-2, with the
CDS classifying 42 (27.6%) of the participants as severelyTable 3 Summary of ANOVA results for depressed and non-d
Total sample (n = 152) Depressed meana (SD) (n = 59)
BDI-II 9.43 (8.92) 17.81 (8.68)
CDS 89.30 (22.72) 103.38 (15.88)
STAI 39.27 (12.98) 48.06 (11.81)
QOL 1 12.97 (3.29) 10.65 (2.80)
QOL 2 14.40 (3.18) 12.28 (2.65)
QOL 3 14.95 (3.68) 13.20 (3.48)
QOL 4 15.42 (2.71) 14.01 (2.20)
ESSI 27.50 (5.90) 26.24 (6.36)
PSSS 66.49 (14.75) 61.10 (14.04)
Note. a = BDI-II > = 10. CDS = Cardiac Depression Scale; BDI-II = Beck Depression Inv
subdomain; QOL 2 = Quality of life psychological subdomain; QOL 3 = Quality of life
subdomain; ESSI = ENRICHD Social Support Instrument; PSSS = Perceived Social Supdepressed whereas the BDI-2 classified only 22 (14.5%)
of participants as such.
Discussion
The aim of this study was to examine the psychometric
properties of the CDS and provide further data to support
the use of the CDS in a CHD population who have been
medically stable and living in their usual community en-
vironment 3.5 months after cardiac hospitalisation.
Consistent with previous research examining the con-
struct validity of the CDS in a cardiac population [26,27]
factor analysis of the CDS yielded six factors rather than
the seven factor solution reported by the authors of the
scale [24]. Four of these factors were almost identical to
the Mood, Anhedonia, Cognition and Sleep Disturbance
factors reported originally [24] and by other researchers
[26,27]. Similar to previous research [24,27], all factors
except Suicidal Ideation demonstrated acceptable reli-
ability and a potential explanation for this may be the
low number of items comprising this factor [27].
There is growing evidence that the CDS is characterized
by adequate psychometric properties when applied to car-
diac samples. Reliability has been found to be high across
cardiac samples when assessed in terms of internal
consistency (coefficient alphas have ranged from 0.88 to
0.92). Moreover, the validity of the CDS has been used
successfully to discriminate between cardiac patients diag-
nosed as depressed vs. nondepressed. The CDS has also
been found to have good concurrent validity with the
BDI-2 (ranging from 0.69 to 0.73) and the STAI (r = 0.80)
[13,26,27]. Consistent with this, the current study also
found that the CDS and the BDI-2 demonstrated good
concurrent validity as seen in the significant correlations
between the CDS and the BDI-2 and the anxiety, quality-
of-life and social support measures [13,24,27]. The corre-
lations between the CDS, BDI-2 and the STAI were within
the ranges found in previous research examining the psy-
chometric properties of the CDS [13]. The moderate toepressed groups
Non-depressed mean (SD) (n = 93) F P η2
4.11 (3.05)
80.37 (21.92) 48.71 < 0.001 .25
33.57 (10.27) 63.26 <0.001 .30
14.45 (2.68) 68.57 <0.001 .32
15.73 (2.74) 57.54 <0.001 .28
16.05 (3.38) 24.60 <0.001 .14
16.31 (2.63) 30.80 <0.001 .17
28.31 (5.47) 4.43 .037 .03
69.91 (14.22) 13.50 <0.001 .09
entory-2; STAI = State Trait Anxiety Inventory; QOL 1 = Quality of life physical
social relationships subdomain; QOL 4 = Quality of life environment
port Scale.
Table 4 Percentages of patients with mild, moderate and severe depression according to the CDS and the BDI-2
Not depressed Mild/moderate depression Severe depression
CDS < 90 BDI-2 < 10 CDS > = 90 BDI-2 (10–18) CDS > = 100 BDI-2 (19+)
(N/%) (N/%) (N/%) (N/%) (N/%) (N/%)
72 (47.4%) 93 (61.2%) 38 (25%) 37 (24.3%) 42 (27.6%) 22 (14.5%)
Note. N = 152; CDS = Cardiac Depression Scale; BDI-2 = Beck Depression Inventory-2.
Kiropoulos et al. BMC Psychiatry 2012, 12:216 Page 6 of 8
http://www.biomedcentral.com/1471-244X/12/216strong correlation between the CDS and the BDI-2 scores
for the current sample indicating a moderate concurrent
validity suggests that the two scales are comparable. Both
the BDI-2 and CDS correlated moderately to strongly with
the STAI. Moderate to strong correlations obtained be-
tween depression and anxiety measures have typically
been found in cardiac populations and may also be indica-
tive of the co-morbid depressive and anxiety symptoms
experienced by these populations [13]. The internal
consistency of the CDS scores in the current study was
compatible with the values obtained by the original
authors and other researchers.
It should be noted that the current sample of CHD
patients reported a high CDS mean score compared to
previous cardiac samples [13]. This may be partly
explained by the high proportion of the current sample
being overseas-born who have been previously found to
have higher levels of depression and anxiety [33] which
could have contributed to the higher mean depression
score. It is possible that depression could have preceded
the development of CHD in these participants.
In the current study, depressed participants were deter-
mined by a BDI-2 score of 10 or more. Both the CDS and
the BDI-2 identified that almost one in four patients (25%
vs. 24.3%) had symptoms indicative of mild to moderate
depression. These results are comparable to those
reported by Wise, Harris and Carter (2006) [27] who
found that the CDS classified 17% of their cardiac out-
patient sample as mild to moderately depressed and other
studies which found mild to moderate depression in 17-
30% of cardiac patients [10,34]
While the BDI-2 suggested that 14.5% had symptoms
indicative of severe depression, the CDS indicated that in
the same cohort, 27.6% of patients were suffering severe
depression which is almost one in three patients as
opposed to almost one in six by the BDI-2. This discrep-
ancy may be due to the CDS items detecting more severe
symptomatology compared to the BDI-2, the cut-off score
used for detecting severe depression with the CDS and the
possibility that the CDS may be overdiagnosing severe de-
pression in this sample. However, these results are com-
parable to previous research which found that the CDS
classified 21-25% of cardiac outpatients as severely
depressed [10,11,15,18,27] and that around one-third of
cardiac patients meet criteria for depression 3 to 4 months
after a cardiac event [28].Limitations and future directions
A major limitation of the current study is that no diagnos-
tic interviews to assess for Major Depressive Disorder or
Episode were concurrently undertaken with participants
to validate the levels of depression found with the CDS
and the BDI-II. The current study was not able to evaluate
the sensitivity or specificity of the CDS in a fully meaning-
ful way. Further research employing larger sample sizes is
required to determine whether the CDS is a more sensi-
tive measure of depression in the 3–4 month time period
after a cardiac event or whether the CDS is yielding more
false positives. The current results need to be replicated
given that the current sample was less than what has been
recommended for conducting factor analysis with sugges-
tions that a minimum sample size of 200 be used [35]. Fu-
ture research should also examine the CDS with other
screening measures for depression and anxiety that have
fewer somatic items such as the Hospital Anxiety and De-
pression Scale (HADS).
Another limitation is that no information was gathered
from those that declined to participate and no compari-
son can be made between this sample and those that
agreed to participate in the current study.
Effective screening after a cardiac event and procedure
has implications for the effective management of depres-
sion to assist cardiac patients in their therapeutic compli-
ance and in their prognosis. Given that those in the
current sample who were depressed also scored lower on
the social support and quality of life measures, overall
treatment approaches should focus on strategies to in-
crease social supports and quality of life in these patients.
Conclusions
Depression has been shown to influence health outcomes
in those with CHD. Accurate and timely assessment of de-
pression in CHD patients has the potential to influence
prognosis and reduce suffering in those who have been
discharged after cardiac hospitalization. The current study
has shown that the CDS can be used to screen and detect
the range of depressive symptomatology, ranging from
mild to severe, in CHD patients who are medically stable
and settled in their community surroundings 3.5 months
following discharge after cardiac hospitalization.
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